Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study
- 27 July 2002
- Vol. 325 (7357) , 197
- https://doi.org/10.1136/bmj.325.7357.197
Abstract
Objective: To develop a model to determine resource costs and health benefits of implementing guidelines for the prevention of cardiovascular disease in primary care Design: Modelling of data from six strategies for prevention of cardiovascular disease. Strategies incorporated two ways of identifying patients for assessment: traditional (assessment of all adults) and novel (preselection of patients for assessment using a prior estimate of their risk of cardiovascular disease). Three treatment strategies were modelled in conjunction witheach identification strategy Setting: England Subjects: Patients aged 30 to 74 eligible for primary prevention strategies for cardiovascular disease who were selected from a hypothetical population of 2000. Main outcome measures:Resource costs of assessing eligible adults, providing treatmentand follow up to those eligible, and number of cardiovascular events this should prevent. Results: Novel strategies prevented more cardiovascular disease, at lower cost, than traditional strategies. Some treatment strategies prevent more cardiovascular disease with fewer resources than others. The findings were robust across a range of different assumptions about workload. Conclusion: Preselecting patients for assessment makes better use of staff time than assessing all adults. Treating many patients with low cost drugs is more efficient than prescribing a few patients intensive antihypertensives and statins. Authors of guidelines should model workload implications and health benefits of following their recommendations.Keywords
This publication has 18 references indexed in Scilit:
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total MortalityJAMA, 1997
- Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and MenAnnals of Internal Medicine, 1997
- Stroke, Statins, and CholesterolStroke, 1997
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Management of raised blood pressure in New Zealand: a discussion document.BMJ, 1993
- The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.British Journal of Clinical Pharmacology, 1993
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991
- An updated coronary risk profile. A statement for health professionals.Circulation, 1991